mail campaign

We posted a number of times about questionable practices Eli Lilly used to market its atypical anti-psychotic drug Zyprexa (olanzapine).

A post from 2007, with links backward, is here, and our most recent post is here.

The company remains entangled in litigation over its marketing of this drug.